Stock listing

NASDAQ:ADXN Addex Therapeutics Ltd Stock

US listing (NASDAQ) of Addex Therapeutics Ltd · home listing SIX Swiss:ADXN

Follow Addex Therapeutics Ltd into a list and get an email when it puts out news.

Share price · NASDAQ:ADXN

$2.89 USD +0.13 (+4.7%)

Close on Oct 19, 2026

Day range
$2.89 – $3.00 USDOct 19, 2026
Volume
3,456 sharesOct 19, 2026
Market value
$5.06M USDAt the close on Oct 19, 2026 · price × 1.75M shares outstanding
Addex Therapeutics Ltd logo
Ticker
NASDAQ:ADXN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Addex Therapeutics (SIX Swiss: ADXN) Q2 2026 Earnings Call

    Mon, Sep 28, 2026 · 10:00 AM ET

    Watch Transcript

  • Addex Therapeutics (SIX Swiss: ADXN) Q1 2026 Earnings Call

    Thu, Jun 25, 2026 · 10:00 AM ET

    Watch Transcript

  • Addex Therapeutics (SIX Swiss: ADXN) Q4 2025 Earnings Call

    Thu, Apr 30, 2026 · 10:00 AM ET

    Watch Transcript

Latest news

Addex Therapeutics Announces Executive Management Changes

Oct 2, 2026

Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update

Sep 28, 2026

Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior

Sep 25, 2026

Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026

Sep 24, 2026

ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027

Aug 26, 2026

Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness

Jul 8, 2026

Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Jun 25, 2026

Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026

Jun 22, 2026

Invitation (432)

Jun 5, 2026

Addex Convenes Annual General Meeting 2026

Jun 5, 2026

All Addex Therapeutics Ltd news

Financings

  • At-the-market programme of shares

    Sep 28, 2026

    Closed: US$2.8M in the latest tranche · H.C. Wainwright & Co.

    Dealers: H.C. Wainwright & Co. (lead)

    Use of proceeds: Advancing the in-house GABAB cough program towards clinical development

    Closed Aug 26, 2026 · Closed Sep 28, 2026

Read by 6ix AI from the company's releases

Decks

Addex Therapeutics Ltd on 6ix

Sector
Health care
Industry
Biotechnology
News releases
20 in the last 12 months · 35 in all · newest Oct 2, 2026 · oldest 2025
Calls
18 calls with a replay · 18 with a transcript · latest Sep 28, 2026
Decks
8 decks · latest October 2026

Where Addex Therapeutics Ltd is listed

ListingExchangeCountryCurrency
SIX Swiss:ADXN · Home listingSIX SwissSwitzerlandCHF
NASDAQ:ADXN · This pageNASDAQUnited StatesUSD
gettex:APEgettexGermanyEUR
Frankfurt:APEFrankfurtGermanyEUR
Stuttgart:APEStuttgartGermanyEUR
LS Exchange:A0MSH6LS ExchangeGermanyEUR
Lang & Schwarz:A0MSH6Lang & SchwarzGermanyEUR
Dusseldorf:APEDusseldorfGermanyEUR
Munich:APEMunichGermanyEUR
BX Swiss:APEBX SwissSwitzerlandCHF
Frankfurt:APE1FrankfurtGermanyEUR
LSE:0QNVLSEUnited KingdomCHF
Aquis:ADXNZAquisUnited KingdomCHF
BOATS:ADXNBOATSUnited StatesUSD
Tradegate:APE1TradegateGermanyEUR
gettex:APE1gettexGermanyEUR
Stuttgart:APE1StuttgartGermanyEUR
Dusseldorf:APE1DusseldorfGermanyEUR
Lang & Schwarz:A3EXC6Lang & SchwarzGermanyEUR
LS Exchange:A3EXC6LS ExchangeGermanyEUR
Munich:APE1MunichGermanyEUR
Turquoise:ADXNZTurquoiseUnited KingdomCHF

Log in to ask 6ix AI your own questions about Addex Therapeutics Ltd.